Brain cancer vaccine–chemotherapy combo shows promise
Findings from a phase I study treating 11 patients with glioblastoma multiforme (GBM) with a combination of an investigational vaccine therapy and an approved chemotherapy drug were published in Clinical Cancer Research.
Making neurosurgery more patient-centric
In his capacity as vice chair of quality of Duke’s Department of Neurosurgery, neurosurgeon Oren Gottfried, MD, has helped develop numerous quality initiatives focusing on improving patient satisfaction and surgical outcomes and reducing patient morbidity and mortality.
Students join Duke neurosurgeons on life-changing trip to Uganda
Duke neurosurgeons visit Uganda twice a year to help train surgeons. This time, they also brought eight middle school boys with them.
Fast access to stroke procedure saves Wilmington woman’s life and health
Duke Raleigh Hospital is one of a handful in NC that offers lifesaving thrombectomy for stroke. Dara Damery got transferred there from Wilmington just in time.
2017 MLK Community Caregiver Award Nominee Dr. Herbert Fuchs
Herbert E. Fuchs, MD, is a Pediatric Neurosurgeon and a licensed pilot who lends his multi-faceted expertise to Children’s Flight of Hope.
Durham Sheriff's Office helps homeless mom whose daughter just had brain surgery
Alexandria Thompson speaks multiple languages. She also suffers from severe seizures that force her mind to switch to Spanish.
At Duke Raleigh Hospital, procedure captures source of a stroke
A new procedure at Duke Raleigh Hospital can help lessen the effects of a stroke.
Brain surgery may get a bit easier, with augmented reality
Neurosurgeons and engineers at Duke are working to make emergency neurosurgical procedures safer with the help the HoloLens, a new pair of augmented reality (AR) goggles from Microsoft.
Breakthrough Status: Duke University Cancer Therapy
For two years, “60 Minutes” followed a clinical trial at Duke University that uses a re-engineered polio virus to attack glioblastoma.
Promising brain cancer trial given breakthrough status by FDA
A therapy using the polio virus to attack glioblastoma has been granted breakthrough status by the Food and Drug Administration. The early results have proven so successful that the FDA wanted to speed the treatment to the market.